FDA Inspection 1257638 — Stanford Blood Center LLC
The FDA completed an inspection of Stanford Blood Center LLC on Dec 17, 2024 in Mountain View, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Dec 17, 2024
- Fiscal Year
- 2025
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Mountain View, CA (United States)